Ortúzar Maite, Esterhuizen Maranda, Olicón-Hernández Darío Rafael, González-López Jesús, Aranda Elisabet
Department of Microbiology and Genetics, Edificio Departamental, University of Salamanca, Salamanca, Spain.
Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, Finland and Helsinki Institute of Sustainability Science, University of Helsinki, Helsinki, Finland.
Front Microbiol. 2022 Apr 26;13:869332. doi: 10.3389/fmicb.2022.869332. eCollection 2022.
The presence of emerging contaminants in the environment, such as pharmaceuticals, is a growing global concern. The excessive use of medication globally, together with the recalcitrance of pharmaceuticals in traditional wastewater treatment systems, has caused these compounds to present a severe environmental problem. In recent years, the increase in their availability, access and use of drugs has caused concentrations in water bodies to rise substantially. Considered as emerging contaminants, pharmaceuticals represent a challenge in the field of environmental remediation; therefore, alternative add-on systems for traditional wastewater treatment plants are continuously being developed to mitigate their impact and reduce their effects on the environment and human health. In this review, we describe the current status and impact of pharmaceutical compounds as emerging contaminants, focusing on their presence in water bodies, and analyzing the development of bioremediation systems, especially mycoremediation, for the removal of these pharmaceutical compounds with a special focus on fungal technologies.
环境中新兴污染物（如药物）的存在是一个日益引起全球关注的问题。全球药物的过度使用，加上传统废水处理系统中药物的难降解性，导致这些化合物呈现出严重的环境问题。近年来，药物的可得性、获取和使用的增加导致水体中药物浓度大幅上升。作为新兴污染物，药物在环境修复领域构成了挑战；因此，人们不断开发传统污水处理厂的替代附加系统，以减轻其影响并降低其对环境和人类健康的危害。在这篇综述中，我们描述了作为新兴污染物的药物化合物的现状和影响，重点关注它们在水体中的存在，并分析生物修复系统，特别是真菌修复系统的发展，以去除这些药物化合物，特别关注真菌技术。
